PubMed HealthSearch

PubMed · 8766246

[Artificial cornea].

Abstract

The cornea is the anterior transparent hole of the eye and its replacement by a synthetic material proves indispensable in some kinds of corneal blindness when penetrating keratoplasty is impossible. For a long time, the keratoprosthesis have been developed by different authors but results were always disappointing. Our personal works have been centered on the utilization of an expanded fluorocarbon polymer as interface between the optic of the keratoprosthesis and the cornea of the recipient. This material has given us a lot of satisfactions but our prosthesis did not meet the criteria of a real artificial cornea because the rigid optic induced mechanical tolerance problems and did not allow the measure of the intraocular pressure. We have developed a new model of artificial cornea with a soft optical zone with a diameter of 6 mm and an haptic made of expanded fluorocarbon polymer pretreated in order to induce a fast cellular ingrowth. We hope that this new optical device could improve optical results and tolerance.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Renard. 1996. [Artificial cornea].. https://pubmed.ncbi.nlm.nih.gov/8766246/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Retinol and retinaldehyde specifically increase alpha1-proteinase inhibitor in the human cornea.

alpha1-Proteinase inhibitor is a serpin and can inhibit most serine proteinases. The cornea is one of several extrahepatic tissues that synthesizes this inhibitor. In the presence of retinol, corneal alpha1-proteinase inhibitor levels were increased 3.8-fold. The maximal response was achieved 2 h after the addition of retinol (1 microM final concentration) to the culture medium. A similar increase in alpha1-proteinase inhibitor was observed with retinaldehyde (1 nM final concentration). Concentrations of alpha1-proteinase inhibitor in other tested cells (Hep G2, CaCo 2, MCF-7, monocytes and macrophages) remained unchanged in the presence of retinol. Retinoic acid did not affect alpha1-proteinase inhibitor levels in the cornea or the other cells tested. The acute-phase cytokine, interleukin-6, increased alpha1-proteinase inhibitor levels in all tested tissues/cells except the cornea. These results demonstrate that alpha1-proteinase inhibitor levels are controlled differently in the cornea compared with other tissues/cells. alpha1-Proteinase inhibitor is the first protein identified whose levels are regulated by a mechanism supported by retinol and retinaldehyde but not retinoic acid.

Cornea